IVERIC BIO/ US46583P1021 /
2023-07-10 10:01:14 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
39.95USD | - | 199,958 Turnover: 7.98 mill. |
-Bid Size: - | -Ask Size: - | 4.07 bill.USD | 0.00% | - |
GlobeNewswire
04-16
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Dir...
GlobeNewswire
04-15
Ocular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessi...
GlobeNewswire
04-10
Oculis Strengthens its Executive Leadership Team with the Appointment of Snehal Shah, Pharm.D. as Pr...
GlobeNewswire
03-04
EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Offic...
GlobeNewswire
02-07
LAPIX Therapeutics Strengthens Board of Directors with Appointments of Pharmaceutical Industry Veter...
GlobeNewswire
2023-12-28
Oxurion Avoids Bankruptcy, Announces Board and Management Changes and Enters into Binding Letter of ...
GlobeNewswire
2023-09-14
Mineralys Therapeutics Expands its Board of Directors with Appointments of Glenn Sblendorio and Daph...
GlobeNewswire
2021-12-03
Akari Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Clinical Progr...
GlobeNewswire
2021-03-17
Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value...
GlobeNewswire
2020-10-08
Oyster Point Pharma Announces Board of Directors Leadership Changes and New Appointment as the Compa...
GlobeNewswire
2020-03-26
PharmaCyte Biotech CEO Discusses Navigating Testing and IND Submission During COVID-19 Pandemic